Ensign Peak Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $540K | Hold |
|
|||||
|
2025
Q1 | $512K | Hold |
|
|||||
|
2024
Q4 | $572K | Hold |
|
|||||
|
2024
Q3 | $467K | Hold |
|
|||||
|
2024
Q2 | $364K | Hold |
|
|||||
|
2024
Q1 | $319K | Sell |
|
|||||
|
2023
Q4 | $602K | Buy |
|
|||||
|
2023
Q3 | $382K | Buy |
|
|||||
|
2023
Q2 | $343K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $302K | Buy |
|
|||||
|
2022
Q2 | $329K | Hold |
|
|||||
|
2022
Q1 | $405K | Buy |
|
|||||
|
2021
Q4 | $711K | Sell |
|
|||||
|
2021
Q3 | $2.9M | Sell |
|
|||||
|
2021
Q2 | $1.97M | Buy |
|
|||||
|
2021
Q1 | $1.31M | Buy |
|
|||||
|
2020
Q4 | $1.29M | Buy |
|
|||||
|
2020
Q3 | $1.01M | Buy |
|
|||||
|
2020
Q2 | $254K | Buy |
|